Prostate cancer subgroup may benefit from intensified therapyMarch 1, 2023Genitourinary CancerProstate CancerOncology
Talazoparib add-on improves outcomes in metastatic prostate cancerFebruary 22, 2023Genitourinary CancerProstate Cancer
Adjuvant nivolumab as standard of care in resected bladder cancerFebruary 22, 2023Genitourinary Cancer
Rucaparib benefit in BRCA+ prostate cancer confirmedFebruary 17, 2023Genitourinary CancerProstate Cancer
Dermoscopy, other modalities for improving melanoma diagnoses reviewedFebruary 7, 2023MelanomaOncology
Gene test may offer insights into treatment response in advanced NSCLCFebruary 7, 2023Lung CancerOncology
Long-course radiation therapy better at organ-sparing in rectal cancer than short-term therapyFebruary 7, 2023Oncology
Most women with breast cancer elude serious COVID-19 vaccine side effectsDecember 16, 2022OncologyBreast Cancer
Exciting advances in HR-positive breast cancer: Top five picks from SABCSDecember 16, 2022Breast CancerOncology
Whole breast radiation for breast cancer shown to be safe and effectiveDecember 1, 2022OncologyBreast Cancer
